1. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC
   Shuwei Wang et al, 2016, Tumor Biology CrossRef
2. Janus kinase 2 inhibition by Licochalcone B suppresses esophageal squamous cell carcinoma growth
   Mengqiu Song et al, 2020, Phytotherapy Research CrossRef
3. Design, synthesis, biological activity evaluation of 3-(4-phenyl-1H-imidazol-2-yl)-1H-pyrazole derivatives as potent JAK 2/3 and aurora A/B kinases multi-targeted inhibitors
   You-Guang Zheng et al, 2021, European Journal of Medicinal Chemistry CrossRef
4. Interleukin-6 and colorectal cancer development
   I.А. Hromakova et al, 2021, Український радіологічний та онкологічний журнал CrossRef
5. Ganoderic acid A exerts antitumor activity against MDA‑MB‑231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway
   Yuguang Yang et al, 2018, Oncology Letters CrossRef
6. Targeting STAT3 in cancer and autoimmune diseases
   Tohid Gharibi et al, 2020, European Journal of Pharmacology CrossRef
7. STAT3 Inhibitors in Cancer: A Comprehensive Update
   Uddalak Bharadwaj et al, 2016, STAT Inhibitors in Cancer CrossRef
8. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling
   Zhang-Bin Tan et al, 2019, Journal of Ethnopharmacology CrossRef
9. Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645�cases from 9 microarray datasets
   Jie‑Yu Wang et al, 2018, Molecular Medicine Reports CrossRef
10. Targeting transcription factor STAT3 for cancer prevention and therapy
    Edna Zhi Pei Chai et al, 2016, Pharmacology & Therapeutics CrossRef
11. Inflammatory genes are novel prognostic biomarkers for colorectal cancer
    Hao Jiang et al, 2018, International Journal of Molecular Medicine CrossRef
12. Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism
    null Marrocco et al, 2019, Cells CrossRef
13. Effects of apigenin pretreatment against renal ischemia/reperfusion injury via activation of the JAK2/STAT3 pathway
    Yang Liu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
14. Fu-Zheng-Tong-Luo formula promotes autophagy and alleviates idiopathic pulmonary fibrosis by controlling the Janus kinase 2/signal transducer and activator of transcription 3 pathway
    Xing Zhang et al, 2023, Journal of Ethnopharmacology CrossRef
15. Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics
    Taiwo Adesoye et al, 2024, Cancers CrossRef
16. STAT3 pathway in cancers: Past, present, and future
    Han‐Qi Wang et al, 2022, MedComm CrossRef
17. The Role of the JAK/STAT Signalling Pathway in Immunoregulation of Gastrointestinal Cancers
    Kris Vaddi, 2017, Immunotherapy for Gastrointestinal Cancer CrossRef
18. 3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells
    Hui Shan et al, 2019, Acta Pharmacologica Sinica CrossRef